In the third quarter, South Korea’s National Pension Service expanded its stake in Amgen Inc. by 3.3%, acquiring an additional 37,747 shares to hold a total of 1,184,060 shares valued at $334.14 million. This stake represents 0.22% of Amgen’s outstanding stock. Other institutional investors were active as well: Twin City Private Wealth LLC added 95 shares to reach 4,283 shares, Winnow Wealth LLC initiated a new $47,000 position, AlphaQuest LLC built a $937,000 stake, Trifecta Capital Advisors LLC boosted its holding by 3.6% to 14,919 shares worth $4.21 million, and Cahill Financial Advisors Inc. opened a $299,000 position. Overall, institutional investors now own 76.50% of the company’s shares.

Senior vice president Nancy A. Grygiel sold 3,139 shares on November 20, reducing her holdings by 30.3%, while executive vice president Murdo Gordon disposed of 6,879 shares on November 12, a 14.1% cut. Together with other transactions, Amgen insiders have sold 10,908 shares valued at $3.67 million over the past 90 days, leaving insiders with 0.76% ownership of the company.

On November 4, Amgen reported third quarter earnings per share of $5.64, surpassing the consensus estimate by $0.63. Revenue came in at $9.56 billion, topping forecasts by $580 million and reflecting a 12.4% year-over-year increase. The company delivered a net margin of 19.47% and a return on equity of 162.59%. Amgen reiterated its full-year 2025 EPS guidance range of 20.60 to 21.40, consistent with analyst expectations around 20.62 EPS.

Amgen announced a quarterly dividend of $2.52, up from $2.38, translating to a $10.08 annual payout and a 2.9% dividend yield, with a payout ratio of 73.6%. On the analyst front, the company holds a consensus “Moderate Buy” rating, supported by one Strong Buy, twelve Buy, ten Hold and one Sell recommendations, reinforcing investor confidence in Amgen’s long-term growth prospects.